Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

V. Conteduca · SciRah

Researcher profile · Semantic Scholar

V. Conteduca

Share profile

V. Conteduca — researcher profile on SciRah

h-index: 45
Works: 241
Citations: 6,682

Most-cited papers

Genome-wide plasma DNA methylation features of metastatic prostate cancer
A. Wu, P. Cremaschi, D. Wetterskog, V. Conteduca +16 more
2020Journal of Clinical Investigation79 citations Open access
Semantic Scholar
Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer
N. Brady, Alyssa M. Bagadion, Richa Singh, V. Conteduca +16 more
2021Nature Communications70 citations Open access
Semantic Scholar
SLFN11 expression in advanced prostate cancer and response to platinum-based chemotherapy
V. Conteduca, S. Ku, L. Puca, M. Slade +12 more
2020Molecular Cancer Therapeutics59 citations Open access
Semantic Scholar
Epigenetics in prostate cancer: clinical implications
V. Conteduca, Judy Hess, Yasutaka Yamada, S. Ku +1 more
2021Translational Andrology and Urology58 citations Open access
Semantic Scholar
Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide
M. Del Re, V. Conteduca, S. Crucitta, G. Gurioli +7 more
2021Prostate Cancer and Prostatic Diseases56 citations Open access
Semantic Scholar
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies
A. Russo, L. Incorvaia, E. Capoluongo, P. Tagliaferri +64 more
2022ESMO Open54 citations Open access
Semantic Scholar
The Immunogenomic Landscape of Neuroendocrine Prostate Cancer
B. Bhinder, A. Ferguson, M. Sigouros, Manik Uppal +9 more
2023Clinical Cancer Research45 citations Open access
Semantic Scholar
New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer
V. Conteduca, A. Mosca, N. Brighi, U. de Giorgi +1 more
2021Cells44 citations Open access
Semantic Scholar
Taxane-induced attenuation of the CXCR2/BCL-2 axis sensitizes prostate cancer to platinum-based treatment.
V. R. de Porras, X. C. Wang, L. Palomero, M. Marín-Aguilera +17 more
2020European Urology44 citations Open access
Semantic Scholar
Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imaging
V. Conteduca, G. Poti, P. Caroli, S. Russi +8 more
2021Therapeutic Advances in Medical Oncology37 citations Open access
Semantic Scholar
Prognostic Role of Circulating Tumor Cells (CTCS) in Metastatic Renal Cell Carcinoma: A Large, Multicenter Prospective Trial.
U. Basso, A. Facchinetti, E. Rossi, M. Maruzzo +19 more
2021The Oncologist35 citations Open access
Semantic Scholar
Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial
U. de Giorgi, M. Sansovini, S. Severi, S. Nicolini +12 more
2021British Journal of Cancer34 citations Open access
Semantic Scholar
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer
V. Conteduca, D. Wetterskog, E. Scarpi, A. Romanel +13 more
2020British Journal of Cancer33 citations Open access
Semantic Scholar
Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy
G. Schepisi, C. Casadei, I. Toma, G. Poti +9 more
2021Cancers31 citations Open access
Semantic Scholar
Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis
V. Conteduca, S. Ku, L. Fernandez, Angel Dago-Rodriquez +12 more
2021npj Precision Oncology28 citations Open access
Semantic Scholar
Circulating Tumor DNA: A New Research Frontier in Urological Oncology from Localized to Metastatic Disease.
Marianna Garofoli, B. Maiorano, Giuseppina Bruno, G. Giordano +5 more
2024European Urology Oncology26 citations Open access
Semantic Scholar
Advanced low grade serous ovarian cancer: A retrospective analysis of surgical and chemotherapeutic management in two high volume oncological centers
P. Di Lorenzo, V. Conteduca, E. Scarpi, M. Adorni +19 more
2022Frontiers in Oncology24 citations Open access
Semantic Scholar
Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis.
P. Rescigno, D. Dolling, V. Conteduca, Mattia Rediti +23 more
2020European Urology Oncology22 citations Open access
Semantic Scholar
Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors
G. Schepisi, V. Conteduca, C. Casadei, G. Gurioli +11 more
2020Frontiers in Oncology21 citations Open access
Semantic Scholar
TRAP1 modulates mitochondrial biogenesis via PGC-1α/TFAM signalling pathway in colorectal cancer cells
Giuseppina Bruno, M. Pietrafesa, F. Crispo, A. Piscazzi +7 more
2024Journal of molecular medicine19 citations Open access
Semantic Scholar
Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis
B. Maiorano, U. de Giorgi, E. Verzoni, E. Maiello +3 more
2023Targeted oncology17 citations Open access
Semantic Scholar
Circulating myeloid-derived suppressor cells and survival in prostate cancer patients: systematic review and meta-analysis
G. Bronte, V. Conteduca, M. Landriscina, A. Procopio
2022Prostate Cancer and Prostatic Diseases17 citations
Semantic Scholar
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation
F. Sanguedolce, M. Zanelli, A. Palicelli, S. Ascani +9 more
2022International Journal of Molecular Sciences17 citations Open access
Semantic Scholar
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide
V. Conteduca, C. Casadei, E. Scarpi, N. Brighi +7 more
2022Cancers17 citations Open access
Semantic Scholar
Combining liquid biopsy and functional imaging analysis in metastatic castration‐resistant prostate cancer helps predict treatment outcome
V. Conteduca, E. Scarpi, P. Caroli, C. Lolli +9 more
2021Molecular Oncology16 citations Open access
Semantic Scholar
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network
P. Rescigno, M. Maruzzo, S. E. Rebuzzi, V. Murianni +19 more
2022The Oncologist14 citations Open access
Semantic Scholar
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists
M. Ottaviano, M. Curvietto, P. Rescigno, M. Tortora +91 more
2020Journal for ImmunoTherapy of Cancer14 citations Open access
Semantic Scholar
Circulating Androgen Receptor for Prognosis and Treatment Selection in Prostate Cancer.
V. Conteduca, D. Wetterskog, E. González-Billalabeitia, N. Brighi +2 more
2021European Urology Oncology13 citations
Semantic Scholar
Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma
V. Conteduca, E. Scarpi, A. Farolfi, N. Brighi +11 more
2021Frontiers in Oncology13 citations Open access
Semantic Scholar
Androgen receptor, PARP signaling, and tumor microenvironment: the ‘perfect triad’ in prostate cancer?
Marianna Garofoli, B. Maiorano, Giuseppina Bruno, G. Giordano +4 more
2024Therapeutic Advances in Medical Oncology12 citations Open access
Semantic Scholar
Evolution of structural rearrangements in prostate cancer intracranial metastases
F. Khani, William F. Hooper, Xiaofei Wang, Timothy R. Chu +14 more
2023npj Precision Oncology12 citations Open access
Semantic Scholar
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO Network
G. Banna, U. Basso, E. Giunta, L. Fratino +20 more
2022Current Oncology12 citations Open access
Semantic Scholar
Circulating tumor cell gene expression and plasma AR gene copy number as biomarkers for castration-resistant prostate cancer patients treated with cabazitaxel
G. Gurioli, V. Conteduca, N. Brighi, E. Scarpi +11 more
2022BMC Medicine12 citations Open access
Semantic Scholar
Personalized Medicine for Metastatic Prostate Cancer: The Paradigm of PARP Inhibitors.
B. Maiorano, V. Conteduca, M. Catalano, L. Antonuzzo +3 more
2023Critical reviews in oncology/hematology11 citations Open access
Semantic Scholar
Pancreatic Enzyme Replacement and Nutritional Support With n ab-Paclitaxel-based First-Line Chemotherapy Regimens in Metastatic Pancreatic Cancer
G. Giordano, R. Cincione, F. Losavio, Tiziano Senia +7 more
2023The Oncologist10 citations Open access
Semantic Scholar
Immune-based Combinations in Intermediate-/Poor-risk Patients with Non-clear Cell Renal Cell Carcinoma: Results from the ARON-1 Study.
F. Massari, V. Mollica, R. M. Kopp, E. Grande +35 more
2025European Urology Focus9 citations
Semantic Scholar
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration‐resistant cancer patients
V. Conteduca, E. Scarpi, D. Wetterskog, N. Brighi +16 more
2021International Journal of Cancer9 citations
Semantic Scholar
Plasma AR Copy Number Changes and Outcome to Abiraterone and Enzalutamide
G. Gurioli, V. Conteduca, C. Lolli, G. Schepisi +5 more
2020Frontiers in Oncology9 citations Open access
Semantic Scholar
Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer
A. Altavilla, C. Casadei, C. Lolli, C. Menna +11 more
2020Expert Opinion on Pharmacotherapy9 citations
Semantic Scholar
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies
M. C. Cursano, A. A. Valsecchi, F. Pantano, M. di Maio +62 more
2024ESMO Open8 citations Open access
Semantic Scholar
A comprehensive review of the role of immune checkpoint inhibitors in elderly patients affected by renal cell carcinoma.
C. Lolli, A. Altavilla, V. Conteduca, A. Farolfi +4 more
2020Critical reviews in oncology/hematology8 citations
Semantic Scholar
Evaluating Treatment Efficacy in Metastatic Hormone-sensitive Prostate Cancer Patients with Visceral Disease: A Systematic Review and Network Meta-analysis.
F. Flauto, G. Neola, Carmine Caso, A. Signori +16 more
2025European Urology Oncology7 citations Open access
Semantic Scholar
SIUrO best practice recommendations to optimize BRCA 1/2 gene testing from DNA extracted from bone biopsy in mCRPC patients (BRCA Optimal Bone Biopsy Procedure: BOP)
A. Cimadamore, P. Rescigno, V. Conteduca, A. Caliò +6 more
2023Virchows Archiv7 citations
Semantic Scholar
Anogenital lichen sclerosus et atrophicus lesions in a case series of cancer patients on immunotherapy
V. Conteduca, M. Medri, L. Mazzoni, U. de Giorgi +1 more
2021Cancer Immunology and Immunotherapy7 citations Open access
Semantic Scholar
Epidemiology of High-risk Biochemical Recurrence After Primary Prostate Cancer Treatment.
U. Falagario, F. Pellegrino, L. Björnebo, A. Abbadi +16 more
2025European Urology Oncology6 citations Open access
Semantic Scholar
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma
Domenico D'Arca, Leda Severi, S. Ferrari, L. Dozza +14 more
2023Cancers6 citations Open access
Semantic Scholar
An update on our ability to monitor castration-resistant prostate cancer dynamics with cell-free DNA
V. Conteduca, N. Brighi, D. Conteduca, S. Bleve +6 more
2021Expert Review of Molecular Diagnostics6 citations
Semantic Scholar
Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study
M. Bourlon, Luca Galli, E. Grande, Se Hoon Park +27 more
2025Frontiers in Oncology5 citations Open access
Semantic Scholar
Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: technical aspects and primary staging setting
M. Bauckneht, L. Evangelista, Luca Sofia, M. Maccauro +338 more
2025Clinical and translational imaging5 citations Open access
Semantic Scholar
Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study’s analysis of heavily pretreated patients
S. Buti, Alessandro Olivari, C. Masini, D. Bimbatti +19 more
2024Therapeutic Advances in Urology5 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

U. de Giorgi×31
Invite
U. de Giorgi — researcher profile on SciRah
C. Lolli×16
Invite
C. Lolli — researcher profile on SciRah
G. Gurioli×14
Invite
G. Gurioli — researcher profile on SciRah
G. Schepisi×14
Invite
G. Schepisi — researcher profile on SciRah

×12

Invite

N. Brighi — researcher profile on SciRah

Invite

C. Casadei — researcher profile on SciRah

Invite

H. Beltran — researcher profile on SciRah

Invite

E. Scarpi — researcher profile on SciRah

Invite

A. Farolfi — researcher profile on SciRah

A. Altavilla×7

Invite

A. Altavilla — researcher profile on SciRah

F. Matteucci×6

Invite

F. Matteucci — researcher profile on SciRah

Invite

M. Maruzzo — researcher profile on SciRah